C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study
Open accessAbstract
Background— The relationship of circulating levels of high-sensitivity C-reactive protein (CRP) with cardiovascular disease (CVD) risk, particularly with consideration of effects at intermediate levels of risk, has not been fully assessed. Methods and Results— Among 3006 offspring participants in the Framingham Heart Study free of CVD (mean age, 46 years at baseline), there were 129 hard coronary heart disease (CHD) events and 286 total CVD events during 12 years of follow-up. Cox regression, discrimination with area under the receiver operating characteristic curve, and net reclassification improvement were used to assess the role of CRP on vascular risk. In an age-adjusted model that included both sexes, the hazard ratios for new hard CHD and total CVD were significantly associated with higher CRP levels. Similar analyses according to increasing homocysteine level showed significant protective associations for hard CHD but not for total CVD. In multivariable analyses that included age, sex, systolic blood pressure, total cholesterol, high-density lipoprotein cholesterol, diabetes mellitus, current smoking, hypertension treatment, and homocysteine, the log CRP level remained significantly related to development of hard CHD and total CVD and provided moderate improvement in the discrimination of events. The net reclassification improvement when CRP was added to traditional factors was 5.6% for total CVD ( P =0.014) and 11.8% for hard CHD ( P =0.009). Conclusions— Circulating levels of CRP help to estimate risk for initial cardiovascular events and may be used most effectively in persons at intermediate risk for vascular events, offering moderate improvement in reclassification of risk.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Many risk factors other than those in available risk functions have been identified, but their contribution to absolute cardiovascular risk estimation in individual patients is generally modest.
“It should be stressed, however, that although many risk factors other than the few included in the available risk functions have been identified [such as C-reactive protein (CRP) and homocysteine levels], their contribution to absolute cardiovascular risk estimations of individual patients (in addition to traditional risk factors) is generally modest.66”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,769 · see citing works
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · see citing works
Self-citationGeneral Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491 · see citing works
Self-citationPencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493 · see citing works
Self-citationPearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401 · see citing works
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · see citing works
PearsonT, A., MensahG, A., & AlexanderR, W. (2003) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200305000-00016 · Cited by 2,937 · see citing works
Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
Cook, N. R. (2007) · Circulation · doi:10.1161/circulationaha.106.672402 · Cited by 2,123 · see citing works
D'Agostino, R. B., Grundy, S., Sullivan, L. M., Wilson, P., & for the CHD Risk Prediction Group (2001) · JAMA · doi:10.1001/jama.286.2.180 · Cited by 2,108 · see citing works
Self-citationVitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972 · see citing works
Self-citationRidker, P. M., Buring, J. E., Rifai, N., & Cook, N. R. (2007) · JAMA · doi:10.1001/jama.297.6.611 · Cited by 1,814 · see citing works
Probability of stroke: a risk profile from the Framingham Study.
Wolf, P. A., D'Agostino, R. B., Belanger, A. J., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.3.312 · Cited by 1,782 · see citing works
Self-citationLong-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., & D, E. B. M. (1999) · Circulation · doi:10.1161/01.cir.100.3.230 · Cited by 1,479 · see citing works
Pencina, M. J., & D’Agostino, R. B. (2004) · Statistics in Medicine · doi:10.1002/sim.1802 · Cited by 1,446 · see citing works
Self-citationGreenland, P. (2007) · Statistics in Medicine · doi:10.1002/sim.2976 · Cited by 1,300 · see citing works
Novel Risk Factors for Systemic Atherosclerosis
Ridker, P. M., Stampfer, M. J., & Rifai, N. (2001) · JAMA · doi:10.1001/jama.285.19.2481 · Cited by 1,300 · see citing works
Pepe, M. S. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh101 · Cited by 1,276 · see citing works
Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis
Selhub, J., Jacques, P. F., Bostom, A. G., D’Agostino, R. B., Wilson, P. W. F., Belanger, A. J., O’Leary, D. H., Wolf, P. A., Schaefer, E. J., & Rosenberg, I. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320502 · Cited by 1,213 · see citing works
Self-citationThe framingham offspring study. Design and preliminary data
Feinleib, M., Kannel, W. B., Garrison, R. J., McNamara, P. M., & Castelli, W. P. (1975) · Preventive Medicine · doi:10.1016/0091-7435(75)90037-7 · Cited by 931 · see citing works
The Framingham Offspring Study
Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Springer eBooks · doi:10.1007/978-3-642-95642-3_25 · Cited by 832 · see citing works
Novel Clinical Markers of Vascular Wall Inflammation
Blake, G. J., & Ridker, P. M. (2001) · Circulation Research · doi:10.1161/hh2101.099270 · Cited by 754 · see citing works
Intermittent Claudication: A Risk Profile From The Framingham Heart Study
Murabito, J. M., D’Agostino, R. B., Silbershatz, H., & Wilson, P. W. F. (1997) · Circulation · doi:10.1161/01.cir.96.1.44 · Cited by 696 · see citing works
Self-citationImproving Coronary Heart Disease Risk Assessment in Asymptomatic People
Greenland, P., Smith, S. C., & Grundy, S. M. (2001) · Circulation · doi:10.1161/hc4201.097189 · Cited by 556 · see citing works
The effect of including C-reactive protein in cardiovascular risk prediction models for women
Cook, N. R., Buring, J. E., & Ridker, P. M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-1-200607040-00128 · Cited by 504 · see citing works
Bostom, A. G., Silbershatz, H., Rosenberg, I. H., Selhub, J., D’Agostino, R. B., Wolf, P. A., Jacques, P. F., & Wilson, P. W. F. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1077 · Cited by 318 · see citing works
Self-citationWilson, P. W. F., Garrison, R. J., Castelli, W. P., Feinleib, M., McNamara, P. M., & Kannel, W. B. (1980) · The American Journal of Cardiology · doi:10.1016/0002-9149(80)90516-0 · Cited by 316 · see citing works
Self-citationAlbert, M. A., Glynn, R. J., & Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000080289.72166.cf · Cited by 269 · see citing works
Wilson, P. W. F., Nam, B., Pencina, M. J., D’Agostino, R. B., Benjamin, E. J., & O’Donnell, C. J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2473 · Cited by 238 · see citing works
Self-citationFolsom, A. R., Aleksic, N., Catellier, D., Juneja, H. S., & Wu, K. K. (2002) · American Heart Journal · doi:10.1067/mhj.2002.124054 · Cited by 225 · see citing works
Ferrario, M., Chiodini, P., Chambless, L. E., Cesana, G., Vanuzzo, D., Panico, S., Sega, R., Pilotto, L., Palmieri, L., & Giampaoli, S. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyh405 · Cited by 214 · see citing works
Vasan, R. S., Beiser, A., D’Agostino, R. B., Levy, D. A., Selhub, J., Jacques, P. F., Rosenberg, I. H., & Wilson, P. W. F. (2003) · JAMA · doi:10.1001/jama.289.10.1251 · Cited by 213 · see citing works
Self-citationC-Reactive Protein Is Associated With Subclinical Epicardial Coronary Calcification in Men and Women
Wang, T. J., Larson, M. G., Levy, D. A., Benjamin, E. J., Kupka, M. J., Manning, W. J., Clouse, M. E., D’Agostino, R. B., Wilson, P. W. F., & O’Donnell, C. J. (2002) · Circulation · doi:10.1161/01.cir.0000032135.98011.c4 · Cited by 176 · see citing works
Self-citationCook, N. R. (2007) · Statistics in Medicine · doi:10.1002/sim.2987 · Cited by 101 · see citing works
Wilson, P. W. F., Anderson, K. M., Castelli, W. P., & Kannel, W. B. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90500-w · Cited by 93 · see citing works
Self-citationTask force #4—how do we select patients for atherosclerosis imaging?
Wilson, P. W. F., Smith, S. C., Blumenthal, R. S., Burke, G. L., & Wong, N. D. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00361-9 · Cited by 64 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [30]Assmann G Schulte H Oberwittler W Fidge NH Nestel PJ New aspects in the prediction of coronary artery disease: The Prospective Cardiovascular Munster Study Atherosclerosis VII 1986 Amsterdam Elsevier 19 24
Cited by
Sorted by citations
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490 · see citing works
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457 · see citing works
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,840 · see citing works
Graham (2007) · doi:10.1097/01.hjr.0000277983.23934.c9 · Cited by 1,647 · see citing works
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Authors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,409 · see citing works
A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure
Tangri, N. (2011) · JAMA · doi:10.1001/jama.2011.451 · Cited by 1,359 · see citing works
Yeboah, J., McClelland, R. L., Polonsky, T. S., Burke, G. L., Sibley, C. T., O’Leary, D., Carr, J. J., Goff, D. C., Greenland, P., & Herrington, D. M. (2012) · JAMA · doi:10.1001/jama.2012.9624 · Cited by 1,122 · see citing works
Predicting the 30-Year Risk of Cardiovascular Disease
Pencina, M. J., D’Agostino, R. B., Larson, M. G., Massaro, J. M., & Vasan, R. S. (2009) · Circulation · doi:10.1161/circulationaha.108.816694 · Cited by 864 · see citing works
Self-citationRidker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799 · see citing works
Erbel, R. M., Möhlenkamp, S., Moebus, S., Schmermund, A., Lehmann, N., Stang, A., Dragano, N., Grönemeyer, D. H. W., Seibel, R. M. M., Kälsch, H., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.030 · Cited by 775 · see citing works
Plasma Proteome Profiling to Assess Human Health and Disease
Geyer, P. E., Kulak, N. A., Pichler, G., Holdt, L. M., Teupser, D., & Mann, M. (2016) · Cell Systems · doi:10.1016/j.cels.2016.02.015 · Cited by 734 · see citing works
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Perk, J., Backer, G. D., Gohlke, H., Graham, I. M., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cífková, R., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.007 · Cited by 693 · see citing works
Buckley, D., Fu, R. F., Freeman, M., Rogers, K. R., & Helfand, M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-7-200910060-00009 · Cited by 557 · see citing works
High-Sensitivity C-Reactive Protein and Cardiovascular Disease
Yousuf, O. K., Mohanty, B. D., Martin, S. S., Joshi, P. H., Blaha, M. J., Nasir, K., Blumenthal, R. S., & Budoff, M. J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.016 · Cited by 495 · see citing works
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.05.037 · Cited by 488 · see citing works
Obesity and Inflammation: Epidemiology, Risk Factors, and Markers of Inflammation
Rodríguez-Hernández, H., Simental‐Mendía, L. E., Ramírez, G. R., & Reyes-Romero, M. A. (2013) · International Journal of Endocrinology · doi:10.1155/2013/678159 · Cited by 484 · see citing works
Cook, N. R., & Ridker, P. M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00007 · Cited by 457 · see citing works
Value and Limitations of Existing Scores for the Assessment of Cardiovascular Risk
Cooney, M. T., Dudina, A. L., & Graham, I. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.020 · Cited by 436 · see citing works
Everett, B. M., Pradhan, A. D., Solomon, D. H., Paynter, N., MacFadyen, J., Zaharris, E., Gupta, M., Clearfield, M., Libby, P., Hasan, A. A. K., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.03.018 · Cited by 368 · see citing works
Coronary Calcium Score Improves Classification of Coronary Heart Disease Risk in the Elderly
Elias‐Smale, S. E., Vliegenthart, R., Koller, M., Kavousi, M., van Rooij, F. J. A., Hunink, M. G. M., Steyerberg, E. W., Albert Hofman, D., Oudkerk, M., & Witteman, J. C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.029 · Cited by 369 · see citing works
Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification: A Cohort Study
Kavousi, M., Elias-Smale, S., Rutten, J. H. W., Leening, M. J. G., Vliegenthart, R., Verwoert, G. C., Krestin, G. P., Oudkerk, M., de Maat, M. P. M., Leebeek, F. W. G., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-6-201203200-00006 · Cited by 360 · see citing works
Grundy, S. M. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.10.001 · Cited by 349 · see citing works
Figueroa, A. L., Abdelbaky, A., Truong, Q. A., Corsini, E. M., MacNabb, M. H., Lavender, Z. R., Lawler, M. A., Grinspoon, S. K., Brady, T. J., Nasir, K., et al. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2013.08.006 · Cited by 336 · see citing works
Statistical methods for assessment of added usefulness of new biomarkers
Pencina, M. J., D’Agostino, R. B., & Vasan, R. S. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.340 · Cited by 335 · see citing works
Self-citationGrundy, S. M., Arai, H., Barter, P. J., Bersot, T. P., Betteridge, D. J., Carmena, R., Cuevas, A. M., Davidson, M. H., Genest, J. J., Kesäniemi, Y. A., et al. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.12.005 · Cited by 328 · see citing works
European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)
Perk, J., Backer, G. D., Gohlke, H., Graham, I. M., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cífková, R., et al. (2012) · International Journal of Behavioral Medicine · doi:10.1007/s12529-012-9242-5 · Cited by 313 · see citing works
Wong, N. D., Budoff, M. J., Ferdinand, K. C., Graham, I. M., Michos, E. D., Reddy, T. K., Shapiro, M. D., & Toth, P. P. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100335 · Cited by 316 · see citing works
Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction
Wang, T. J. (2011) · Circulation · doi:10.1161/circulationaha.109.912568 · Cited by 295 · see citing works
Ezaz, G. Z., Long, J. B., Gross, C. P., & Chen, J. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000472 · Cited by 279 · see citing works
Cardiorespiratory Fitness and Classification of Risk of Cardiovascular Disease Mortality
Gupta, S. K., Rohatgi, A. K., Ayers, C. R., Willis, B. L., Haskell, W. L., Khera, A., Drazner, M. H., de Lemos, J. A., & Berry, J. D. (2011) · Circulation · doi:10.1161/circulationaha.110.003236 · Cited by 236 · see citing works
Prognostic Value of Stress Myocardial Perfusion Positron Emission Tomography
Dorbala, S., Carli, M. F. D., Beanlands, R. S., Merhige, M. E., Williams, B. A., Veledar, E., Chow, B. J. W., Min, J. K., Pencina, M. J., Berman, D. S., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.043 · Cited by 233 · see citing works
Self-citationC-reactive protein is a mediator of cardiovascular disease
Bisoendial, R. J., Boekholdt, S. M., Vergeer, M., Stroes, E. S. G., & Kastelein, J. J. P. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq238 · Cited by 232 · see citing works
Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, G. D. B. (. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312450228 · Cited by 863 · see citing works
Cooney, M. T., Dudina, A., D'Agostino, R., & Graham, I. M. (2010) · Circulation · doi:10.1161/circulationaha.109.852756 · Cited by 222 · see citing works
Self-citationLin, J. S., Evans, C. V., Johnson, E., Redmond, N., Coppola, E. L., & Smith, N. (2018) · JAMA · doi:10.1001/jama.2018.4242 · Cited by 216 · see citing works
Ridker, P. M. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.119214 · Cited by 206 · see citing works
Homocysteine and Reclassification of Cardiovascular Disease Risk
Veeranna, V., ZALAWADIYA, S. K., Niraj, A., Pradhan, J., Ference, B. A., Burack, R. C., Jacob, S., & Afonso, L. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.028 · Cited by 213 · see citing works
Avan, A., Tavakoly Sany, S. B., Ghayour‐Mobarhan, M., Rahimi, H. R., Tajfard, M., & Ferns, G. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26791 · Cited by 182 · see citing works
Shah, N. N., Parikh, V. K., Patel, N., Patel, N., Badheka, A., Deshmukh, A. J., Rathod, A. D., & Lafferty, J. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.019 · Cited by 183 · see citing works
Pathophysiology of coronary artery disease leading to acute coronary syndromes
Ambrose, J. A., & Singh, M. (2015) · F1000Prime Reports · doi:10.12703/p7-08 · Cited by 175 · see citing works
Rosenberg, S. J., Elashoff, M. R., Beineke, P., Daniels, S. E., Wingrove, J. A., Tingley, W. G., Sager, P. T., Sehnert, A. J., Yau, M., Kraus, W. E., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-7-201010050-00005 · Cited by 172 · see citing works
F. Piepoli, M. (2017) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9583-6 · Cited by 162 · see citing works
Geriatric Conditions and Subsequent Mortality in Older Patients With Heart Failure
Chaudhry, S. I., Wang, Y., Gill, T. M., & Krumholz, H. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.066 · Cited by 155 · see citing works
Elkhawad, M., Rudd, J. H. F., Sarov‐Blat, L., Cai, G., Wells, R., Davies, C., Collier, D., Marber, M. S., Choudhury, R. P., Fayad, Z. A., et al. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.02.016 · Cited by 152 · see citing works
Muntendam, P., McCall, C. J., Sanz, J., Falk, E., & Fuster, V. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.02.021 · Cited by 146 · see citing works
Novel biomarkers of cardiovascular disease: Applications in clinical practice
Lyngbakken, M. N., Myhre, P. L., Røsjø, H. R., & Omland, T. (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1525335 · Cited by 143 · see citing works
Out, D., Hall, R. J., Granger, D. A., Page, G. G., & Woods, S. J. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.01.019 · Cited by 137 · see citing works
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · Kardiologia Polska · doi:10.5603/kp.2016.0120 · Cited by 143 · see citing works
Optimizing Statin Treatment for Primary Prevention of Coronary Artery Disease
Hayward, R. A., Krumholz, H. M., Zulman, D. M., Timbie, J. W., & Vijan, S. S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00004 · Cited by 131 · see citing works
Inflammation in Coronary Artery Disease
Christodoulidis, G., Vittorio, T. J., Fudim, M., Lerakis, S., & Kosmas, C. E. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000006 · Cited by 127 · see citing works
The influence of hip circumference on the relationship between abdominal obesity and mortality
Cameron, A. J., Magliano, D. J., Shaw, J. E., Zimmet, P., Carstensen, B., Alberti, K. G. M. M., Tuomilehto, J. O., Barr, E., Pauvaday, V., Kowlessur, S., et al. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr198 · Cited by 119 · see citing works
Zhang, R., Zhang, Y. Y., Huang, X. R., Wu, Y., Chung, A. C. K., Wu, E. X., Szalai, A. J., Yu, W. B. C., Lau, C., & Lan, H. Y. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.140608 · Cited by 117 · see citing works
KONES, R. J. (2010) · Drug Design Development and Therapy · doi:10.2147/dddt.s10812 · Cited by 111 · see citing works
Seyedsadjadi, N., & Grant, R. (2020) · Antioxidants · doi:10.3390/antiox10010015 · Cited by 104 · see citing works
Comorbidity in inflammatory bowel disease
López–Sanromán, A. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i22.2723 · Cited by 102 · see citing works
Mora, S., Musunuru, K., & Blumenthal, R. S. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.109728 · Cited by 101 · see citing works
Khera, A., Budoff, M. J., O’Donnell, C. J., Ayers, C. R., Locke, J. P., de Lemos, J. A., Massaro, J. M., McClelland, R. L., Taylor, A. J., & Levine, B. D. (2018) · Circulation · doi:10.1161/circulationaha.118.033505 · Cited by 97 · see citing works
Self-citationCritical appraisal of inflammatory markers in cardiovascular risk stratification
Krintus, M., Koziński, M., Kubica, J., & Sypniewska, G. (2014) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2014.913549 · Cited by 90 · see citing works
DNA methylation biomarkers of myocardial infarction and cardiovascular disease
Fernández‐Sanlés, A., Sayols-Baixeras, S., Subirana, I., Sentı́, M., Pérez-Fernández, S., Moura, M. D. C., Esteller, M., Marrugat, J., & Elosúa, R. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01078-6 · Cited by 84 · see citing works
Monteiro, J., Leslie, M. A., Moghadasian, M. H., Arendt, B. M., Allard, J. P., & David, W. L. (2014) · Food & Function · doi:10.1039/c3fo60551e · Cited by 82 · see citing works
Dillon, M. C., Opris, D., Kopanczyk, R., Lickliter, J., Cornwell, H. N., Bridges, E. G., Nazar, A. M., & Bridges, K. G. (2010) · Biomarker Insights · doi:10.4137/bmi.s5305 · Cited by 81 · see citing works
Risk prediction in cardiovascular disease: The prognostic significance of endothelial dysfunction
Martin, B., & Anderson, T. J. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)71049-9 · Cited by 79 · see citing works
Epidemiology, Traditional and Novel Risk Factors in Coronary Artery Disease
Mack, M. C., & Gopal, A. (2015) · Heart Failure Clinics · doi:10.1016/j.hfc.2015.08.002 · Cited by 76 · see citing works
Ely, B. R., Francisco, M. A., Halliwill, J. R., Bryan, S. D., Comrada, L. N., Larson, E. A., Brunt, V. E., & Minson, C. T. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00078.2019 · Cited by 74 · see citing works
Batsis, J. A., & López-Jiménez, F. A. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-29 · Cited by 71 · see citing works
Identifying novel biomarkers for cardiovascular disease risk prediction
Ge, Y., & Wang, T. J. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02589.x · Cited by 71 · see citing works
Chandrashekara, S. (2014) · Internet Journal of Rheumatology and Clinical Immunology · doi:10.15305/ijrci/v2is1/117 · Cited by 65 · see citing works
Closing the loop on inflammation and atherothrombosis: why perform the CIRT and CANTOS trials?
Ridker, P. M. (2013) · Europe PMC (PubMed Central) · Cited by 64 · see citing works
Veeranna, V., ZALAWADIYA, S. K., Niraj, A., Kumar, A., Ference, B. A., & Afonso, L. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.11.034 · Cited by 65 · see citing works
Classical and Novel Biomarkers for Cardiovascular Risk Prediction in the United States
Folsom, A. R. (2013) · Journal of Epidemiology · doi:10.2188/jea.je20120157 · Cited by 64 · see citing works
Ridker, P. M., MacFadyen, J. G., Nordestgaard, B. G., Köenig, W., Kastelein, J. J. P., Genest, J. J., & Glynn, R. J. (2010) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.938118 · Cited by 64 · see citing works
D, E. B. M. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr310 · Cited by 64 · see citing works
Impaired retinal vasodilator responses in prediabetes and type 2 diabetes
Lott, M. E. J., Slocomb, J. E., Shivkumar, V., Smith, B., Quillen, D. A., Gabbay, R. A., Gardner, T. W., & Bettermann, K. (2013) · Acta Ophthalmologica · doi:10.1111/aos.12129 · Cited by 63 · see citing works
New and Emerging Risk Factors for Coronary Heart Disease
Akhabue, E., Thiboutot, J. P., Cheng, J.-W., Lerakis, S., Vittorio, T. J., Christodoulidis, G., Grady, K. M., & Kosmas, C. E. (2013) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31828aab45 · Cited by 61 · see citing works
High-sensitivity C reactive protein and risk of cardiovascular disease in China-CVD study
Dong, Y., Wang, X., Zhang, L., Chen, Z., Zheng, C., Wang, J., Kang, Y., Shao, L., Tian, Y., & Wang, Z. (2018) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2018-211433 · Cited by 60 · see citing works
Jiang, Y., Zhang, X., Ma, R., Wang, X., Liu, J., Keerman, M., Yan, Y., Ma, J., Song, Y., Zhang, J., et al. (2021) · Clinical Epidemiology · doi:10.2147/clep.s313343 · Cited by 59 · see citing works
Rana, J. S., Cote, M., Després, J., Sandhu, M. S., Talmud, P. J., Ninio, E., Wareham, N. J., Kastelein, J. J. P., Zwinderman, A. H., Khaw, K., et al. (2009) · Heart · doi:10.1136/hrt.2009.170134 · Cited by 58 · see citing works
C-reactive protein is a bystander of cardiovascular disease
Anand, S. S., & Yusuf, S. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq242 · Cited by 56 · see citing works
Epidemiology, Traditional and Novel Risk Factors in Coronary Artery Disease
Mack, M. C., & Gopal, A. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.04.003 · Cited by 55 · see citing works
Sever, P., Poulter, N. R., Chang, C., Hingorani, A. D., Thom, S., Hughes, A. D., Welsh, P. I., Sattar, N. A., & on behalf of the ASCOT Investigators (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr262 · Cited by 55 · see citing works
Serum C-reactive protein level and prediabetes in two Asian populations
Sabanayagam, C., Shankar, A., Lim, S. C., Lee, J., Tai, E. S., & Wong, T. Y. (2011) · Diabetologia · doi:10.1007/s00125-011-2052-5 · Cited by 51 · see citing works
C-reactive protein and cardiovascular risk in the general population
Kurt, B., Reugels, M., Schneider, K. M., Spießhoefer, J., Milzi, A., Gombert, A., Fordyce, C. B., Wenzl, F. A., Pagidipati, N. J., Rocha, V. Z., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf937 · Cited by 50 · see citing works
CVD screening in low-risk, asymptomatic adults: clinical trials needed
Polonsky, T. S., & Greenland, P. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.114 · Cited by 50 · see citing works
Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis
Ortíz, A., Massy, Z. A., Fliser, D., Lindholm, B., Więcek, A., Martínez‐Castelao, A., Covic, A. C., Goldsmith, D. J. A., Süleymanlar, G., London, G. M., et al. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.170 · Cited by 49 · see citing works
Elevated Pulmonary Artery Systolic Pressure Predicts Heart Failure Admissions in African Americans
Choudhary, G., Jankowich, M. D., & Wu, W. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001366 · Cited by 49 · see citing works
High-Sensitive C-Reactive Protein: Universal Prognostic and Causative Biomarker in Heart Disease?
Rietzschel, E. R., & Buyzere, M. D. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.11.108 · Cited by 47 · see citing works
Association of Serum Procalcitonin With Cardiovascular Prognosis in Coronary Artery Disease
Sinning, C., Sinning, J., Schulz, A., Schnabel, R. B., Lubos, E., Wild, P. S., Papassotiriou, J., Bergmann, A., Blankenberg, S., Münzel, T. F., et al. (2011) · Circulation Journal · doi:10.1253/circj.cj-10-0638 · Cited by 47 · see citing works
Abd, T. T., Eapen, D. J., Bajpai, A., Goyal, A., Dollar, A. L., & Sperling, L. S. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0164-5 · Cited by 47 · see citing works
The Emerging Role of Inflammation in Cardiovascular Disease
Martinez, B. K., & White, C. M. (2018) · Annals of Pharmacotherapy · doi:10.1177/1060028018765939 · Cited by 48 · see citing works
Risk and the Physics of Clinical Prediction
McEvoy, J. W., Diamond, G. A., Detrano, R., Kaul, S., Blaha, M. J., Blumenthal, R. S., & Jones, S. R. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.01.418 · Cited by 46 · see citing works
C-Reactive Protein and Colorectal Cancer Mortality in U.S. Adults
Goyal, A., Terry, M. B., Jin, Z., & Siegel, A. B. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0577 · Cited by 45 · see citing works
Early identification of atherosclerotic disease by noninvasive imaging
Fuster, V., Lois, F., & Franco, M. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.54 · Cited by 44 · see citing works
Shaw, L. J., Wilson, P. W. F., Hachamovitch, R., Hendel, R. C., Borges‐Neto, S., & Berman, D. S. (2010) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2010.09.008 · Cited by 43 · see citing works
Self-citationPark, C., Do, J. G., Lee, Y., & Yoon, K. J. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-021232 · Cited by 42 · see citing works
Lee, J., Ryu, S., Cheong, E., & Sung, K. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.08.003 · Cited by 41 · see citing works
Methods for evaluating novel biomarkers - a new paradigm
Cook, N. R. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02469.x · Cited by 38 · see citing works
Cardoso, C. R. L., Leite, N. C., & Salles, G. F. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004554 · Cited by 36 · see citing works
Ormseth, M. J., Solus, J. F., Sheng, Q., Chen, S., Ye, F., Wu, Q., Oeser, A. M., Allen, R. M., Raggi, P., Vickers, K. C., et al. (2021) · Clinical Rheumatology · doi:10.1007/s10067-020-05573-8 · Cited by 36 · see citing works
Wang, X., Wang, J., Wu, S., Ni, Q., & Chen, P. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s328882 · Cited by 36 · see citing works
- Authors
- Wilson, P. W. F., Pencina, M., Jacques, P., Selhub, J., D'Agostino, R., & O'Donnell, C. J.
- Affiliations
- Boston University (US)
- From EPICORE (P.W.F.W.), Emory University School of Medicine, and the Atlanta VAMC Epidemiology and Genetics Section, Atlanta, Ga; National Heart, Lung, and Blood Institute (C.J.O.D.); National Heart, Lung and Blood Institute’s Framingham Heart Study (M.P., R.D.A., C.J.O.D.), Framingham Mass; Department of Mathematics (M.P., R.D.A.), Boston University, Boston, Mass; Tufts USDA Nutrition Center (P.J., J.S.), Boston, Mass.
- Venue
- Circulation: Cardiovascular Quality and Outcomes
- Published
- 2008-11
- Volume
- 1
- Issue
- 2
- Pages
- 92-97
- ISSN
- 1941-7705 (ISSN-L)
- 1941-7713
- PMC
- PMC3033831
- OpenAlex
- W2144684988
- Cited by
- 299
- References
- 38
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 3 · 2023: 13 · 2022: 8 · 2021: 16 · 2020: 6 · 2019: 5 · 2018: 19 · 2017: 12 · 2016: 20 · 2015: 15 · 2014: 21 · 2013: 18 · 2012: 36
- FWCI
- 29.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation Cardiovascular Quality and Outcomes (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- School of Medicine, Boston University
- Centre International de Recherche sur le Cancer
- National Institutes of Health (n01hc25195-41-0-1)
- National Heart, Lung, and Blood Institute (R01HL073272, N01‐HC25195, N01-HC-025195)
- Topics
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- C-reactive protein, cardiovascular risk reclassification, coronary artery disease, cardiovascular disease, intermediate cardiovascular risk, homocysteine, risk prediction, net reclassification improvement
- MeSH terms
- Adult, C-Reactive Protein, Coronary Disease, Female, Follow-Up Studies, Homocysteine, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Biomarkers, Prevalence, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
